Indian Journal of Animal Research

  • Chief EditorK.M.L. Pathak

  • Print ISSN 0367-6722

  • Online ISSN 0976-0555

  • NAAS Rating 6.43

  • SJR 0.263

  • Impact Factor 0.5 (2023)

Frequency :
Monthly (January, February, March, April, May, June, July, August, September, October, November and December)
Indexing Services :
Science Citation Index Expanded, BIOSIS Preview, ISI Citation Index, Biological Abstracts, Scopus, AGRICOLA, Google Scholar, CrossRef, CAB Abstracting Journals, Chemical Abstracts, Indian Science Abstracts, EBSCO Indexing Services, Index Copernicus
Submit

Research Article

Indian Journal of Animal Research, volume 54 issue 3 (march 2020) : 363-366

Meloxicam induced toxicopathology studies in Wistar rats

S. Pramod Bharani, A.K. Naik, S.C. Parija, S.K. Panda
1Department of Veterinary Pharmacology and Toxicology, College of Veterinary Science and Animal Husbandry, Odisha University of Agriculture and Technology, Bhubaneshwar-751 003, Orissa, India.
Cite article:- Bharani Pramod S., Naik A.K., Parija S.C., Panda S.K. (2019). Meloxicam induced toxicopathology studies in Wistar rats. Indian Journal of Animal Research. 54(3): 363-366. doi: 10.18805/ijar.B-3766.

ABSTRACT

Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most commonly used class of drugs for treating inflammation and pain.  Meloxicam has analgesic, anti-inflammatory and antipyretic properties and is a commonly used NSAID in veterinary practice. The present study was done to evaluate effect of meloxicam on toxico-pathological and hematological parameters in Wistar rats. Eighteen Wistar rats were equally divided into three groups i.e. Group I, Group II and Group III. Group I (negative control) rats received only Normal saline (0.9%) @ 1ml/kg. Group II (Low dose) received meloxicam@ 4 mg/kg B.W. and Group III (High dose) rats received meloxicam@8 mg/kg B.W. orally by gavage for 28 days. Dose-dependent clinical signs and lesions were observed after meloxicam treatment. Kidneys and liver were severely hemorrhagic at the high dose, while intestine and stomach had ulcers and erosions. Hematological values were altered after 28 days of administration. Total Erythrocyte Count (TEC), Packed Cell Volume (PCV), Haemoglobin values were decreased and TLC count was significantly increased in both doses of meloxicam treated groups in a dose-dependent manner. It was concluded that meloxicam caused GIT lesions, nephrotoxicity, hepatotoxicity and variation in the hematological parameters at selected dose and duration.

REFERENCES

  1. Ahmad, M.Y., Abdul-Fattah, J.H., Aziz, F.M. (2015).The protective role of vitamin C against the hepatotoxic and nephrotoxic effect of meloxicam in male mice. IOSR Journal of Pharmacy and Biological Sciences, 10: 69-73.
  2. Alencar, M.M., Pinto, M.T., Oliveria, D.M. (2003).Margin of safety of meloxicam: deleterious effect on blood cells and GIT. Ciencia Rural, 33: 525-532.
  3. Al-Rekabi, F., Abbas, D. and Hadi, N. (2009). Effects of sub chronic exposure to meloxicam on some hematological, biochemical and liver histopathological parameters in rats. Iraqi Journal of Veterinary Sciences, 23: 249–254.
  4. Atzpodien, E., Mehdi, N., Clarke, D. and Radhofer, S. (1997). Subacute and chronic oral toxicity of lornoxicam in cynomolgusmonkeys. Food and Chemical Toxicology, 35: 465-474.
  5. Baggaley, E., Nielsen, S., Marples, D. (2010). Dehydration induced increase in aquaporin-2 protein abundance is blocked by nonsteroidal anti-inflammatory drugs. American Journal of Physiology-Renal Physiology, 4: 1051–1058.
  6. Bhadja, N.D. (2007). Sub-acute oral toxicity study of meloxicam in Wistar rats. M.V.Sc thesis submitted to Anand Agricultural University, Anand.
  7. Burukoglu, D., Baycu, C., Taplamacioglu, F., Sahin, E., and Bektur, E. (2014). Effects of nonsteroidal anti-inflammatory meloxicam on stomach, kidney, and liver of rats. Toxicology and Industrial Health, 32:980-986
  8. El-Halfawy I.E.(2009). Comparative toxicity study of meloxicam and etodolac, publication by University of Sadat City.
  9. Fleischmann, R., Iqbal, I. and Slobodin, G. (2002). Meloxicam. Expert Opinion on Pharmacotherapy, 3:1501-1512
  10. Mahaprabhu, R., Bhandarkar, A.G., Jangir, B.L., Rahangadale, S.P. and Kurkure, N.V. (2011) Ameliorative effect of Ocimum Sanctum on meloxicam induced toxicity in Wistar rats. Toxicology International, 18: 130–136.
  11. Merchant, M. A. and Modi, D. N. (2004).Acute and chronic effects of aspirin on hematological parameters and hepatic ferritin expression in mice. Indian Journal of Pharmacology, 36: 226-230.
  12. Nakagawa, K., Yamagami, T. and Takemura, N. (2005). Hepatocellular toxicosis associated with the alternate administration of carprofen and meloxicam in a Siberian husky. TheJournal of Veterinary Medical Science, 67:1051-1053.
  13. Ogino, K., Harada, Y. and Hatanaka, K. (1996). Inhibitory effect of Meloxicam on COX-2. At the 69th Annual Meeting of Japanese Pharmacological Society, Nagasaki, Japan.
  14. Ramesh, N., Jayakumar, K., Honnegowda, Narayana, K. and Vijayasarathi, S.K. (2001). Nimesulide toxicity in dogs. Indian Journal of Pharmacology, 33:217-218.
  15. Seddik, H. and Rabhi, M. (2013). Meloxicam-induced colitis revealed by acute abdominal pain. Annales Pharmaceutiques Francaises, 71: 119-122
  16. Sharma, A.B. (2002). Studies on the Efficacy of Certain Non-Steroidal Anti-inflammatory Drugs. M.V.Sc. Thesis, J.N.K.V.V., Jabalpur.
  17. Sternon, J.and Appelboo11m, T. (1998). Meloxicam, Revue Medicale de Bruxelles, 19:29-32.
  18. Taiwo, V. O. and Conteh O. L. (2008). The rodenticidal effect of indomethacin: pathogenesis and pathology. Journal Veterinarski Arhiv, 78:167- 178.
  19. Tanaka, A., Hase, S., Miyazawa,T.and Takeuchi, K. (2002). Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: a key to nonsteroidal anti-inflammatory drug-induced intestinal damage. Journal of Pharmacology and Experimental Therapeutics, 300:754-761.
  20. Vane, J.R. and Botting, R.M. (1997). Mechanism of action of aspirin-like drugs, Seminars in Arthritis and Rheumatism, 26: 2–10.
  21. Villegas,I., Casa, C.L., Lastra, C. A., Motilva, V., Herrerias, J.M. and Martin, M.J. (2003). Mucosal damage induced by preferential COX-1 and COX-2 inhibitors, Role of prostaglandins and inflammatory response. Life Sciences, 74: 873 – 884
In this Article
    Contact us
    Follow us

    Editorial Board

    View all (0)